Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 11/06/2024 9:48:45 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 7410
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
70995
I appreciated Alan Cs daily report on trading.
(3)
Jimvette
01/03/2022 11:02:19 AM
70994
AlanC regrettably passed away.
(2)
someconcerns
01/03/2022 9:59:49 AM
70993
Does anyone know whereabout AlanC?
Zadie
01/03/2022 7:30:45 AM
70992
Early, but new variant possibly greater than
(1)
djs7
01/02/2022 11:18:15 PM
70991
Let's pray Brilacidin can find its specific path
(1)
djs7
01/02/2022 10:19:43 PM
70987
Found this post on another site. Am currently
(7)
petemantx
12/30/2021 4:49:55 PM
70982
Hope everyone had a Merry Christmas and is
(7)
scgmck1
12/29/2021 10:25:24 PM
70980
Initially I was very disturbed with the PR
(8)
petemantx
12/27/2021 8:38:39 PM
70979
As frustrations mount over the need for, what
(2)
Commando911
12/27/2021 12:52:02 AM
70978
So if you have migraines or certain heart
(3)
Drano
12/27/2021 12:07:13 AM
70977
Ritonavir, part of part of Pfizer's covid pill
(5)
farrell
12/26/2021 11:43:01 PM
70976
Great post farrell. We have all read about safety
(6)
Mo
12/26/2021 11:49:20 AM
70975
At this point none of the other antiviral drugs
(11)
farrell
12/26/2021 10:59:11 AM
70972
Thanks and same to you and the board as well.
(3)
Kelt
12/25/2021 3:14:01 PM
70968
Second the motion. Merry Christmas and let's hope
(5)
Drano
12/25/2021 11:02:42 AM
70967
Merry Christmas to you and all who
(5)
someconcerns
12/25/2021 6:31:36 AM
70966
Merry Christmas, folks!
(5)
Commando911
12/24/2021 10:56:00 PM
70965
Maybe Leo will apply for a NIIMBL grant from the
Commando911
12/23/2021 10:04:23 AM
70961
Response to a post on another board. Post:
(3)
Kelt
12/21/2021 6:03:41 PM
70959
Good information. The "broad spectrum" potential
bandg
12/21/2021 9:14:37 AM
70958
Links:
(2)
farrell
12/21/2021 9:05:24 AM
70956
The multi-identity just wants to soft bash. But
(3)
Drano
12/20/2021 4:29:32 PM
70955
The "Fat Lady" hasn't sung yet on the P2 results
(5)
Kelt
12/20/2021 3:49:14 PM
70954
Brilacidin phase 2 test suggested they did not
(4)
airplaneguy
12/20/2021 3:06:09 PM
70953
With Regeneron's covid antiviral "antibiotic"
(12)
farrell
12/19/2021 12:10:14 AM
70952
IPIX has a distinct advantage over Galera and
(4)
bandg
12/16/2021 1:50:16 PM
70949
Nice soft-bashing. Galera's drug initially failed
(6)
Drano
12/16/2021 2:22:45 AM
70948
Lilly's Mirikizumab for UC. Galera's GC4419 for
(3)
bandg
12/15/2021 8:41:20 PM
70947
This is a fascinating read. it's no wonder that
(6)
Fit007
12/15/2021 8:00:18 AM
70946
GREAT Brilacidin link from another site. True
(5)
petemantx
12/14/2021 8:10:18 PM
70945
Agreed.
bandg
12/14/2021 6:33:15 PM
70944
That's quite the endorsement of B....that alone
(7)
Chemdeps
12/14/2021 5:57:12 PM
70943
Current university article with mention of
(4)
bandg
12/14/2021 5:34:30 PM
70941
Russian State Register of Medicines status,
(1)
crashco
12/13/2021 9:44:42 AM
70936
Thats easy, Drano. Because theres a whole
(10)
scgmck1
12/08/2021 9:50:42 PM
70934
Glad to see that the multi-identities are
(3)
Drano
12/08/2021 4:05:40 PM
70932
Seems logical that they would continue until
(1)
bandg
12/08/2021 3:09:05 PM
70931
hahaha he's having to sign in under several
(3)
Drano
12/08/2021 3:01:18 PM
70930
The big question I have is why multi-identities
(5)
Drano
12/08/2021 1:40:43 PM
70929
So the big question I have is...are doctors still
(3)
Chemdeps
12/08/2021 11:52:36 AM
70928
On what? Whom are you speaking
(2)
scgmck1
12/07/2021 9:28:33 PM
70927
$IPIX ICYMI
(1)
TonyCorvette
12/07/2021 7:38:14 AM
70925
I'd think any compassionate use analysis could
(1)
bandg
12/06/2021 7:03:33 PM
70923
Easy to find as to Remdesivir recommended
(1)
bandg
12/06/2021 5:39:36 PM
70922
Attached is an article I found online just now by
(3)
petemantx
12/06/2021 4:37:43 PM
70920
Pete, I believe the Yahoo author is incorrect
(11)
Mo
12/06/2021 1:24:24 PM
70915
I found this link on another site and what
(5)
petemantx
12/05/2021 9:25:04 AM
70914
I'd be bettinglarge on that one !!
(3)
Kelt
11/30/2021 10:20:53 PM
70912
How amusing that the scum multiple identity
(8)
Drano
11/30/2021 10:02:32 AM
70910
How far will scum go to manipulate stock price?
(5)
Drano
11/30/2021 9:48:44 AM
Newer
Older
Recent Articles
Market Movers: Insights on Coinbase, MicroStrategy, and More
Bosch's Strategic Shift: Reducing Hours for Thousands in Germany
Investigation of Mergers: MKFG, CYTH, BRKH, and CFB Explored
Wolfspeed Investors: Join the Fight for Justice and Recovery
Legal Action for ASML Investors: Take Charge Now
Short Selling: A Growing Trend Amid Market Fluctuations
Lead Class Action Opportunity for Hasbro Investors Amid Losses
Xerox Holdings Corporation Class Action: Key Investor Info
Election Outcomes Signal Shift in Housing Support and Strategies
Mark Cuban Advocates for Leadership Growth Over Micromanagement
Spirit Airlines Takes Strategic Step With Chapter 11 Filing
Investors Urged to Join Class Action Against PACS Group Inc.
Nvidia's Future Looks Bright as Chip Demand Remains Strong
Robert Kiyosaki Champions Bitcoin Investment Strategy by Saylor
Investors Encouraged to Seek Legal Counsel for $JENNER Case
UPS and BIT Mining Fined in Major Financial Misconduct Cases
Allan Leighton Returns to Lead Asda as Executive Chairman
Kaskela Law Investigates Innovid Corp. Buyout Deal for Investors
Concerns Arise Over Zuora, Inc. Shareholder Privileges Amid Acquisition
MicroStrategy's Michael Saylor Hails $500M Daily Profit from Bitcoin
Empowering Lilium N.V. Investors: Your Rights and Options
Huawei Sets Ambitious Goal of 100,000 Apps on Harmony OS
Brazil's Government Takes Action to Freeze Spending Amid Fiscal Rulings
Understanding the Fed's Rate Strategy and Future Prospects
Citi's Insights on Oil Price Surge and Economic Impact
Potential Impacts of a Second Trump Administration on Trade
Understanding Market Dynamics: Pullbacks and Rally Threats
Cautiously Optimistic: Natural Gas Price Trends for 2025
Record Financial Remedies Achieved by US SEC in 2024
Exploring the Impact of EV Tax Credit Changes on Stocks
Seven & i Holdings Family Explores Buyout Options with KKR
Chamath Palihapitiya Proposes Simplifying Tax System for All
Global Reactions to Potential Tariff Policies Under Trump
Market Trends: Stocks to Watch This Week Beyond Expectations
Nvidia Speeds Up Samsung's AI Memory Chips for Market Demand
Moody's A3 Upgrade: A Positive Turn for Cyprus' Economy
U.S. Nuclear Energy: Growth and Localization Trends
SpaceX's Starship Selected for Lunar Rover Mission Milestone
Implications of Kennedy Jr's Appointment on U.S. Food Policies
Volkswagen's ID.2 Electric Vehicle: A Game Changer for EVs
VanEck's Bold Prediction on Bitcoin Price Surge and Investor Strategy
FTX Set to Start Paying Back Customers and Creditors Soon
Volkswagen's ID.2: A Game-Changer in Affordable EVs by 2025
Meta's Legal Challenges Intensify After Supreme Court Ruling
The Environmental Impact of Fossil Fuel Exports in Egypt
SEC Achieves Unprecedented $8.2 Billion in Penalties for 2024
IMF Boosts Support with $333 Million for Sri Lanka's Recovery
Adani Group CFO Responds to US Bribery Indictment Allegations
Edwards Lifesciences Investors: Lead Class Action Opportunity
Russia's Controversial Emissions Claims Spark Outrage at COP29